Trademark: TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
Click here to search for trademarks similar to TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
Proof of use for TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
We do not have any records of a proof of use for TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES at this moment.
Click here to add a proof of use for TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
Possible trademark infringements of TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
Basic Information about TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
- Serial Number
- 97769288
- Filing Date
- 26 Jan 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES on the blockchain with WikiTrademarks.io.
- First use of TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES?
1. Replimune Limited Abingdon, Oxfordshire
Correspondent
- MELANIE HOWARD
- LOEB & LOEB LLP
- 10100 SANTA MONICA BOULEVARD, SUITE 2200
- LOS ANGELES, CA 90067
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io